Table 2 Patient clinical characteristics.

BMI

32.6 (13.6)

History of smoking/tobacco use; n = 20

10 (50%)

Pregnant

1 (5%)

SOFA score on admission

1 (2)

Days in hospital

11 (17)

Died in hospital

3 (14%)

Received blood transfusion during stay

5 (24%)

Units received

4 (16)

Use of anticoagulants prior to admission

3 (14%)

Aspirin

2 (10%)

Rivaroxaban

1 (5%)

Received anticoagulants in hospital

19 (91%)

Apixaban

3 (14%)

Aspirin

2 (10%)

Enoxaparin sodium

10 (48%)

Heparin

5 (24%)

Rivaroxaban

1 (5%)

Use of immunosuppressants (for transplant)

3 (14%)

Hematology

RBCs (10⁶/µL)

n = 21

4.40 (0.68)

M: 4.0–5.7

F: 3.9–5.1

WBCs (10³/µL)

n = 20

9.7 (6.2)

4.5–11.0

Platelets (10³/µL)

n = 20

226 (123)

153–367

Hemoglobin (g/dL)

n = 20

12.4 (3.8)

M: 12.6–17.4

F: 11.9–15.7

Hematocrit (%)

n = 20

37.8 (10.2)

M: 37–50

F: 35–45

MCV (fL)

n = 19

89.8 (8.2)

80–96

MCHC (g/dL)

n = 19

31.7 (2)

28–33

RDW (%)

n = 19

15.0 (3.6)

12–15%

Absolute lymphocyte count (10³/µL)

n = 18

0.6 (0.6)

1.3–3.5

Absolute neutrophil count (10⁶/µL)

n = 19

7.3 (6.1)

1.7–7.3

Coagulation

d-dimer (ng/mL)

n = 17

2190 (4125)

 ≤ 500

PT (s)

n = 10

14.0 (3.6)

12.1–15.0

PTT (s)

n = 11

29 (11)

25–38

INR

n = 10

1.0 (0.4)

2.0–3.0

Chemistry

Sodium (mmol/L)

n = 21

137 (4)

136–145

Potassium (mmol/L)

n = 21

4.1 (0.3)

3.5–5.1

BUN (mg/dL)

n = 21

22 (26.5)

M: 9–20

F: 7–17

Bicarbonate (mmol/L)

n = 21

29 (11)

21–30

Bilirubin (mg/dL)

n = 19

0.6 (0.3)

0.2–1.3

Creatinine (mg/dL)

n = 21

1.04 (0.89)

M: 0.66–1.25

F: 0.52–1.04